Shionogi Announces Global Phase 3 Trial Demonstrates Post-Exposure Prophylactic Use of Ensitrelvir Prevents Symptomatic COVID-19
Shionogi just announced that their antiviral pill, ensitrelvir, significantly prevents COVID transmission!
Participants took the antiviral after known exposure.